rdf:type |
|
lifeskim:mentions |
umls-concept:C0006141,
umls-concept:C0007124,
umls-concept:C0008976,
umls-concept:C0015737,
umls-concept:C0021853,
umls-concept:C0039286,
umls-concept:C0087111,
umls-concept:C0543467,
umls-concept:C1522673,
umls-concept:C1709701,
umls-concept:C2587213
|
pubmed:issue |
9169
|
pubmed:dateCreated |
1999-6-29
|
pubmed:abstractText |
We have shown previously that lumpectomy with radiation therapy was more effective than lumpectomy alone for the treatment of ductal carcinoma in situ (DCIS). We did a double-blind randomised controlled trial to find out whether lumpectomy, radiation therapy, and tamoxifen was of more benefit than lumpectomy and radiation therapy alone for DCIS.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0140-6736
|
pubmed:author |
pubmed-author:BegovicMM,
pubmed-author:DignanKK,
pubmed-author:DimitrovN VNV,
pubmed-author:FehrenbacherLL,
pubmed-author:FisherBB,
pubmed-author:FisherE RER,
pubmed-author:KardinalC GCG,
pubmed-author:KavanahM TMT,
pubmed-author:MamounasEE,
pubmed-author:MargoleseR GRG,
pubmed-author:OishiR HRH,
pubmed-author:SmithRR,
pubmed-author:WickerhamD LDL,
pubmed-author:WolmarkNN
|
pubmed:issnType |
Print
|
pubmed:day |
12
|
pubmed:volume |
353
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1993-2000
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10376613-Antineoplastic Agents, Hormonal,
pubmed-meshheading:10376613-Breast Neoplasms,
pubmed-meshheading:10376613-Carcinoma, Intraductal, Noninfiltrating,
pubmed-meshheading:10376613-Carcinoma, Lobular,
pubmed-meshheading:10376613-Carcinoma in Situ,
pubmed-meshheading:10376613-Combined Modality Therapy,
pubmed-meshheading:10376613-Double-Blind Method,
pubmed-meshheading:10376613-Female,
pubmed-meshheading:10376613-Humans,
pubmed-meshheading:10376613-Mastectomy, Segmental,
pubmed-meshheading:10376613-Middle Aged,
pubmed-meshheading:10376613-Survival Rate,
pubmed-meshheading:10376613-Tamoxifen
|
pubmed:year |
1999
|
pubmed:articleTitle |
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
|
pubmed:affiliation |
National Surgical Adjuvant Breast and Bowel Project, Allegheny University of the Health Sciences, Pittsburgh, PA 15212-5234, USA. bfisher@aherf.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|